Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Establishing an Accurate Microhardness Testing Protocol for Craniofacial Tissues
Published on: April 26, 2024
NOD2 contributes to Porphyromonas gingivalis-induced bone resorption
T P Prates1, T M Taira2, M C Holanda2
1Department of Pediatric Dentistry, School of Dentistry of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Abstract:
The NOD-like receptors are cytoplasmic proteins that sense microbial by-products released by invasive bacteria. Although NOD1 and NOD2 are functionally expressed in cells from oral tissues and play a role triggering immune responses, the role of NOD2 receptor in the bone resorption and in the modulation of osteoclastogenesis is still unclear. We show that in an experimental model of periodontitis with Porphyromonas gingivalis W83, NOD2(-/-) mice showed lower bone resorption when compared to wild type. Quantitative polymerase chain reaction analysis revealed that wild-type infected mice showed an elevated RANKL/OPG ratio when compared to NOD2(-/-) infected mice. Moreover, the expression of 2 osteoclast activity markers-cathepsin K and matrix metalloproteinase 9-was significantly lower in gingival tissue from NOD2(-/-) infected mice compared to WT infected ones. The in vitro study reported an increase in the expression of the NOD2 receptor 24 hr after stimulation of hematopoietic bone marrow cells with M-CSF and RANKL. We also evaluated the effect of direct activation of NOD2 receptor on osteoclastogenesis, by the activation of this receptor in preosteoclasts culture, with different concentrations of muramyl dipeptide. The results show no difference in the number of TRAP-positive cells. Although it did not alter the osteoclasts differentiation, the activation of NOD2 receptor led to a significant increase of cathepsin K expression. We confirm that this enzyme was active, since the osteoclasts resorption capacity was enhanced by muramyl dipeptide stimulation, evaluated in osteoassay plate. These results show that the lack of NOD2 receptor impairs the bone resorption, suggesting that NOD2 receptor could contribute to the progression of bone resorption in experimental model of periodontitis. The stimulation of NOD2 by its agonist, muramyl dipeptide, did not affect osteoclastogenesis, but it does favor the bone resorption capacity identified by increased osteoclast activity.
Insights
The NOD2 receptor plays a key role in bone resorption during periodontitis. Lack of NOD2 reduces bone loss, while its activation enhances osteoclast activity and bone resorption.
Area of Science:
- Immunology
- Oral Biology
- Bone Biology
Background:
- NOD-like receptors (NLRs) are cytoplasmic sensors of microbial products.
- NOD1 and NOD2 are expressed in oral tissues and involved in immune responses.
- The specific role of NOD2 in periodontitis-associated bone resorption and osteoclastogenesis remains unclear.
Purpose of the Study:
- To investigate the role of the NOD2 receptor in experimental periodontitis.
- To determine NOD2's influence on bone resorption and osteoclast differentiation.
- To examine the effect of NOD2 activation on osteoclast activity and bone resorption capacity.
Main Methods:
- Utilized a mouse model of periodontitis induced by Porphyromonas gingivalis.
- Compared bone resorption, RANKL/OPG ratio, and osteoclast marker expression in NOD2(-/-) and wild-type mice.
- Conducted in vitro studies on hematopoietic bone marrow cells and preosteoclasts, stimulating NOD2 with muramyl dipeptide.
Main Results:
- NOD2(-/-) mice exhibited significantly lower bone resorption and reduced expression of osteoclast markers (cathepsin K, MMP-9) in experimental periodontitis.
- Wild-type infected mice showed a higher RANKL/OPG ratio compared to NOD2(-/-) infected mice.
- In vitro, NOD2 activation did not alter osteoclast differentiation but increased cathepsin K expression and osteoclast resorption capacity.
Conclusions:
- The absence of the NOD2 receptor impairs bone resorption in experimental periodontitis.
- NOD2 signaling contributes to the progression of bone resorption in periodontitis.
- NOD2 activation enhances osteoclast activity and bone resorption capacity, independent of osteoclastogenesis.
Related Concept Videos
The Oral Microbiota
Osteoclasts in Bone Remodeling

